首页> 美国卫生研究院文献>EMBO Reports >RNF152 positively regulates TLR/IL‐1R signaling by enhancing MyD88 oligomerization
【2h】

RNF152 positively regulates TLR/IL‐1R signaling by enhancing MyD88 oligomerization

机译:RNF152通过增强MyD88寡聚化来积正调节TLR / IL-1R信号传导

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Toll‐like receptors (TLRs) are important pattern recognition receptors (PRRs) that are critical for the defense against invading pathogens. IL‐1β is an important pro‐inflammatory cytokine that also plays pivotal roles in shaping the adaptive immune response. TLRs and interleukin‐1 receptor (IL‐1R) share similar cytosolic domains and signaling processes. In this study, we identify the E3 ubiquitin ligase RNF152 as a positive regulator of TLR/IL‐1R‐mediated signaling. Overexpression of RNF152 potentiates IL‐1β‐ and LPS‐induced NF‐κB activation in an ubiquitination‐independent manner, whereas knockdown of RNF152 has the opposite effects. RNF152‐deficient mice produce less inflammatory cytokines in response to LPS and are more resistant to LPS‐induced lethal endotoxemia. Mechanistically, RNF152 interacts with the adaptor protein MyD88 and enhances oligomerization of MyD88, which is essential for the recruitment of downstream signaling components and activation of TLR/IL‐1R‐mediated signal transduction. Our findings suggest that RNF152‐mediated oligomerization of MyD88 is important for TLR/IL‐1R‐mediated inflammatory response.
机译:Toll样受体(TLR)是重要的模式识别受体(PRR),对于防御侵袭病原体至关重要。 IL-1β是一种重要的促炎细胞因子,也起到塑造适应性免疫应答的关键作用。 TLR和白细胞介素-1受体(IL-1R)共享类似的细胞溶质结构域和信号传导过程。在该研究中,我们将E3泛素连接酶RNF152鉴定为TLR / IL-1R介导的信号传导的正调节剂。 RNF152的过度表达具有独立于普遍的方式的IL-1β和LPS诱导的NF-κB活化,而RNF152的敲低具有相反的效果。 RNF152缺陷小鼠响应于LPS产生较少的炎性细胞因子,并且对LPS引起的致死内毒血症更耐药。机械地,RNF152与适配器蛋白质MyD88相互作用,增强MyD88的低聚,这对于募集下游信号传导组分和TLR / IL-1R介导的信号转导的激活至关重要。我们的研究结果表明,RNF152介导的MYD88的低聚,对于TLR / IL-1R介导的炎症反应很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号